Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 |
|---|---|---|---|
| Total Revenue | 9.9M | 6.6M | -- |
| Operating Revenue | 10.1M | 6.7M | -- |
| Cost Of Revenue | 8.2M | 5.8M | -- |
| Gross Profit | 1.6M | 800,000 | -- |
| Selling General And Administration | 875,000 | 416,000 | -- |
| General And Administrative Expense | 219,000 | 227,000 | -- |
| Depreciation And Amortization In Income Statement | 58,000 | 39,000 | -- |
| Other Operating Expenses | 49,000 | 26,000 | -- |
| Operating Expense | 982,000 | 481,000 | -- |
| Operating Income | 667,000 | 319,000 | -- |
| EBIT | 514,000 | -14,000 | -- |
| Interest Expense | 17,000 | 0.00 | -- |
| Interest Expense Non Operating | 17,000 | 0.00 | -- |
| Interest Income | 10,000 | 2,000 | -- |
| Interest Income Non Operating | 10,000 | 2,000 | -- |
| Net Interest Income | -20,000 | 2,000 | -- |
| Other Income Expense | -150,000 | -335,000 | -- |
| Other Non Operating Income Expenses | -139,000 | -37,000 | -- |
| Special Income Charges | 0.00 | -337,000 | -- |
| Write Off | 0.00 | 337,000 | -- |
| Gain On Sale Of Security | -11,000 | 39,000 | -- |
| Pretax Income | 497,000 | -14,000 | -- |
| Tax Provision | 137,000 | 78,000 | -- |
| Tax Effect Of Unusual Items | -3,032 | -119,200 | -- |
| Net Income From Continuing And Discontinued Operation | 360,000 | -92,000 | -- |
| Net Income From Continuing Operation Net Minority Interest | 360,000 | -92,000 | -- |
| Net Income Including Noncontrolling Interests | 360,000 | -92,000 | -- |
| Net Income Common Stockholders | 360,000 | -92,000 | -- |
| Net Income | 360,000 | -92,000 | -- |
| EBITDA | 572,000 | 25,000 | -- |
| Normalized EBITDA | 583,000 | 323,000 | -- |
| Reconciled Depreciation | 58,000 | 39,000 | -- |
| Basic EPS | 0.13 | -0.03 | -- |
| Diluted EPS | 0.13 | -0.03 | -- |
| Basic Average Shares | 2.7M | 2.7M | -- |
| Diluted Average Shares | 2.7M | 2.7M | -- |
| Total Unusual Items | -11,000 | -298,000 | -- |
| Total Unusual Items Excluding Goodwill | -11,000 | -298,000 | -- |
| Tax Rate For Calcs | 0.28 | 0.40 | -- |
| Normalized Income | 367,968 | 86,800 | -- |
| Depreciation Amortization Depletion Income Statement | 58,000 | 39,000 | -- |
| Depreciation Income Statement | 58,000 | 39,000 | -- |
| Diluted NI Availto Com Stockholders | 360,000 | -92,000 | -- |
| Net Income Continuous Operations | 360,000 | -92,000 | -- |
| Net Non Operating Interest Income Expense | -20,000 | 2,000 | -- |
| Other Gand A | 194,000 | 79,000 | -- |
| Reconciled Cost Of Revenue | 8.2M | 5.8M | -- |
| Salaries And Wages | 25,000 | 148,000 | -- |
| Selling And Marketing Expense | 656,000 | 189,000 | -- |
| Total Expenses | 9.2M | 6.3M | -- |
| Total Operating Income As Reported | 528,000 | -55,000 | -- |
| Total Other Finance Cost | 13,000 | -- | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 546,000 | 210,000 | 727,000 |
| Cash Cash Equivalents And Short Term Investments | 546,000 | 210,000 | 727,000 |
| Accounts Receivable | 116,000 | 208,000 | 307,000 |
| Receivables | 167,000 | 815,000 | 660,000 |
| Inventory | 3.1M | 924,000 | 377,000 |
| Current Assets | 3.8M | 1.9M | 1.8M |
| Gross PPE | 465,000 | 67,000 | 25,000 |
| Accumulated Depreciation | -80,000 | -30,000 | -- |
| Net PPE | 385,000 | 37,000 | 25,000 |
| Total Non Current Assets | 385,000 | 37,000 | 25,000 |
| Total Assets | 4.2M | 2.0M | 1.8M |
| Current Debt And Capital Lease Obligation | 48,000 | 36,000 | -- |
| Accounts Payable | 505,000 | 499,000 | 168,000 |
| Payables | 2.5M | 901,000 | 427,000 |
| Payables And Accrued Expenses | 2.5M | 906,000 | 427,000 |
| Current Accrued Expenses | 59,000 | 5,000 | -- |
| Current Liabilities | 2.6M | 942,000 | 427,000 |
| Long Term Debt And Capital Lease Obligation | 199,000 | 0.00 | 0.00 |
| Long Term Capital Lease Obligation | 199,000 | 0.00 | 0.00 |
| Total Non Current Liabilities Net Minority Interest | 232,000 | 0.00 | 4,000 |
| Total Liabilities Net Minority Interest | 2.8M | 942,000 | 431,000 |
| Common Stock | 0.00 | 0.00 | 0.00 |
| Capital Stock | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 1.4M | 1.0M | 1.4M |
| Common Stock Equity | 1.4M | 1.0M | 1.4M |
| Stockholders Equity | 1.4M | 1.0M | 1.4M |
| Total Equity Gross Minority Interest | 1.4M | 1.0M | 1.4M |
| Total Capitalization | 1.4M | 1.0M | 1.4M |
| Net Tangible Assets | 1.4M | 1.0M | 1.4M |
| Tangible Book Value | 1.4M | 1.0M | 1.4M |
| Working Capital | 1.3M | 1.0M | 1.3M |
| Invested Capital | 1.4M | 1.0M | 1.4M |
| Total Debt | 247,000 | 36,000 | 0.00 |
| Share Issued | 4.0M | 4.0M | 4.0M |
| Ordinary Shares Number | 4.0M | 4.0M | 4.0M |
| Buildings And Improvements | 330,000 | 57,000 | -- |
| Capital Lease Obligations | 247,000 | 36,000 | 0.00 |
| Current Capital Lease Obligation | 48,000 | 36,000 | 0.00 |
| Duefrom Related Parties Current | 0.00 | 284,000 | 338,000 |
| Finished Goods | 3.1M | 924,000 | 377,000 |
| Interest Payable | 7,000 | 0.00 | -- |
| Non Current Deferred Liabilities | 33,000 | 0.00 | 4,000 |
| Non Current Deferred Taxes Liabilities | 33,000 | 0.00 | 4,000 |
| Other Payable | 2.0M | 402,000 | 259,000 |
| Other Properties | 135,000 | 10,000 | 25,000 |
| Other Receivables | 51,000 | 323,000 | 15,000 |
| Properties | 0.00 | 0.00 | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 |
|---|---|---|---|
| Operating Cash Flow | 523,000 | -306,000 | -- |
| Cash Flow From Continuing Operating Activities | 524,000 | -306,000 | -- |
| Depreciation And Amortization | 58,000 | 39,000 | -- |
| Depreciation Amortization Depletion | 58,000 | 39,000 | -- |
| Deferred Tax | 33,000 | -4,000 | -- |
| Deferred Income Tax | 33,000 | -4,000 | -- |
| Change In Working Capital | 81,000 | -222,000 | -- |
| Changes In Account Receivables | 92,000 | 99,000 | -- |
| Change In Receivables | 2.4M | -155,000 | -- |
| Change In Inventory | -2.2M | -547,000 | -- |
| Change In Payables And Accrued Expense | -147,000 | 480,000 | -- |
| Change In Payable | -147,000 | 480,000 | -- |
| Other Non Cash Items | -5,000 | 3,000 | -- |
| Capital Expenditure | -132,000 | -2,000 | -- |
| Purchase Of PPE | -132,000 | -2,000 | -- |
| Net PPE Purchase And Sale | -132,000 | -2,000 | -- |
| Investing Cash Flow | -132,000 | -2,000 | -- |
| Cash Flow From Continuing Investing Activities | -132,000 | -2,000 | -- |
| Repayment Of Debt | -59,000 | -24,000 | -- |
| Net Issuance Payments Of Debt | -59,000 | -24,000 | -- |
| Common Stock Dividend Paid | 0.00 | -223,000 | -- |
| Financing Cash Flow | -59,000 | -247,000 | -- |
| Cash Flow From Continuing Financing Activities | -59,000 | -247,000 | -- |
| Effect Of Exchange Rate Changes | 4,000 | 38,000 | -- |
| Changes In Cash | 332,000 | -555,000 | -- |
| Beginning Cash Position | 210,000 | 727,000 | -- |
| End Cash Position | 546,000 | 210,000 | -- |
| Free Cash Flow | 391,000 | -308,000 | -- |
| Income Tax Paid Supplemental Data | 158,000 | 0.00 | -- |
| Interest Paid Supplemental Data | 17,000 | 0.00 | -- |
| Cash Dividends Paid | 0.00 | -223,000 | -- |
| Depreciation | 58,000 | 39,000 | -- |
| Gain Loss On Sale Of PPE | 0.00 | 8,000 | -- |
| Long Term Debt Payments | -59,000 | -24,000 | -- |
| Net Foreign Currency Exchange Gain Loss | -4,000 | -38,000 | -- |
| Net Income From Continuing Operations | 360,000 | -92,000 | -- |
| Net Long Term Debt Issuance | -59,000 | -24,000 | -- |
| Operating Gains Losses | -4,000 | -30,000 | -- |